Overview
Superior NanoBioSystems specializes in analysis, development, and implementation of technology. Through strategic partnerships with both the MEMS & Nanotechnology Exchange and DARPA, we address critical operational and medical needs for both government and industry clients. We have four core areas of expertise that include:
Feasibility analysis of technology concepts
We have conducted extensive analysis in the area of antigen-antibody reactions in blood groups. Our analysis efforts have shown that the multiple sampling of thousands of different kinds of bacterial pathogens using these reactions can yield critical information quickly. Using bio-electronic sensor components tailored to detect gaseous and liquid compounds, our technology provides a measurable increase in speed of detection, accuracy of diagnostic information, and cost-effectiveness of addressing this issue.
Analysis of technological alternatives
We thoroughly examine emergent technologies to fully leverage state-of the-art ideas to address requirements. Recognizing that there is a seldom a “single point solution”, we strive to examine and integrate technologies that are both proven and experimental. For example, our surface micro fluidic modification techniques could allow for genetic analysis of many kinds of viral pathogens on a single biochip system. These techniques draw from various emergent technologies to assure a comprehensive solution.
Comparison of emergent technologies
We continue to examine and compare various technologies to fully address areas that might prove useful in solving emergent problems. We examine current detection systems that are non-micro fluidic as well as other microfluidic systems. There are merits to all of the technologies and we strive to examine the best possible alternative or combination of alternatives.
Platform development to support medical and bio-defense initiatives
We have developed a rugged, hand-held, field-deployable, diagnostic platform capable of sampling for thousands of unique antigens. Designed for use in remote areas and in mass casualty situations, this platform is capable of detecting chemical and biological agents in time-critical situations. This platform is extremely valuable when conditions cannot support the more cumbersome and time-intensive devices that are typically used today. In addition, this platform is capable of serving as a handheld blood typing device for operational medical requirements.